Financials

  • Market Capitalization 1.83 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.67
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2032
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
7.30 USD-4.45%-17.51%+10.61%+211.97%1.90 B USD
2040
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.70 USD+0.18%-7.32%-3.23%+100.70%1.86 B USD
2060
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
20.10 USD+4.20%+0.90%+5.73%+24.69%1.79 B USD
2067
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.33 USD-2.06%-4.86%+9.90%-29.15%1.78 B USD

新闻